Navigation Links
Cell Therapeutics, Inc. Announces Institutional Investors Purchase $30 Million of Preferred Stock and Warrants
Date:6/29/2011

and have no voting rights on general corporate matters.

The closing of the offering is expected to occur on July 5, 2011, at which time the Company will receive the cash proceeds and deliver the securities.

Rodman & Renshaw, LLC, a wholly-owned subsidiary of Rodman & Renshaw Capital Group, Inc., (Nasdaq: RODM), acted as the exclusive placement agent for the offering.  Trout Capital LLC provided financial advisory services.

A shelf registration statement relating to the shares of Series 13 Preferred Stock and warrants issued in the offering (and the shares of common stock issuable upon conversion of the Series 13 Preferred Stock and exercise of the warrants) has been filed with the Securities and Exchange Commission (the "SEC"). A prospectus supplement under Rule 424 of the Securities Act of 1933, as amended, relating to the offering will be filed with the SEC. Copies of the prospectus supplement and accompanying prospectus may be obtained directly from the Company by contacting the Company at the following address: Cell Therapeutics, Inc., 501 Elliott Avenue West, Suite 400, Seattle, Washington 98119. This press release does not constitute an offer to sell or a solicitation of an offer to buy the Series 13 Preferred Stock or warrants (or the shares of common stock issuable upon conversion of the Series 13 Preferred Stock and exercise of the warrants). No offer, solicitation or sale will be made in any jurisdiction in which such offer, solicitation or sale is unlawful.

This press release includes forward-looking statements that involve a number of risks and uncertainties, the outcome of which could materially and/or adversely affect actual future results and the trading prices of the Company's securities. The risks and uncertainties include the risk that the purchase and sale of the Series 13 Preferred Stock and related warrants might not be
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cell Therapeutics, Inc. Reports Outcome of Special Meeting of Shareholders
2. Serina Therapeutics, Inc. Closes $9.5 Million Financing Round
3. Cancer Research UK Signs Deal With Centella Therapeutics, Inc. to Launch Clinical Development of Radiotherapy-Enhancing Drug
4. Cell Therapeutics, Inc. Announces Institutional Investors Purchase Approximately $16.0 Million of Preferred Stock and Warrants
5. Cell Therapeutics, Inc. Reports First Quarter Accomplishments and Financial Results
6. Vista Partners Updates Coverage on Opexa Therapeutics, Inc.; Maintains Target Price of $6.50
7. Orexigen® Therapeutics, Inc. Announces Upcoming Departure of Chief Financial Officer
8. Cell Therapeutics, Inc. (CTI) to Report Fourth Quarter and Year-End 2010 Financial Results on February 16
9. Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc.
10. Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for Pixuvri®
11. Veteran Pharmaceutical Executives Form New American Therapeutics, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... Insulet Corporation (NASDAQ: PODD ), the ... ® Insulin Management System, today announced preliminary revenue ... The Company also announced that it will postpone the ... conference call from Thursday, July 30, as originally scheduled. ... , Preliminary second quarter revenue ...
(Date:7/29/2015)... to data released today by the Centers for Medicare ... D premium is expected to remain stable at $32.50, ... Pharmaceutical Care Management Association (PCMA) said. "The ... spot in American health care. By offering an abundance ... edge, cost-saving tools like pharmacy networks and home delivery ...
(Date:7/29/2015)... , July 29, 2015 Unilife Corporation ... developer, manufacturer and supplier of injectable drug delivery ... platform of instant patch pumps for insulin. ... wearable insulin pump that does not require filling ... prefilled and pre-assembled like an insulin pen, only ...
Breaking Medicine Technology:Insulet Reports Preliminary Second Quarter 2015 Revenue Results 2Insulet Reports Preliminary Second Quarter 2015 Revenue Results 3Insulet Reports Preliminary Second Quarter 2015 Revenue Results 4Insulet Reports Preliminary Second Quarter 2015 Revenue Results 5Unilife Introduces World's First Instant Patch Pump for Insulin 2Unilife Introduces World's First Instant Patch Pump for Insulin 3Unilife Introduces World's First Instant Patch Pump for Insulin 4
(Date:7/29/2015)... ... July 30, 2015 , ... Avid collector, Andrew Hawley from Vintage Rock Posters, ... posters. The same poster art was used for the Charlotte Coliseum show a month ... and are classic boxing style concert posters. , They measure 22 x 28 ...
(Date:7/29/2015)... ... July 29, 2015 , ... According to data released ... Part D premium is expected to remain stable at $32.50, a figure far lower ... Part D program continues to be a bright spot in American health care. By ...
(Date:7/29/2015)... ... July 29, 2015 , ... Sports fans young and old at ... former players of the Detroit Lions, joined by A Forever Recovery, a holistic treatment ... Wide Receiver Herman Moore, Pro Bowl Offensive Lineman Lomas Brown, and Tight End Rob ...
(Date:7/29/2015)... ... July 29, 2015 , ... This past week, CARE Surrogacy Center ... a treasured member of the CARE extended family. , By shedding light on ... parents across the globe gain a newfound perspective on surrogacy in Mexico. The center ...
(Date:7/29/2015)... FL (PRWEB) , ... July 29, 2015 , ... ... have become increasingly aware of the impact drinking and substance abuse is having ... illness. Financial loss is tagged in the billions per year. [1] Will Wesch, ...
Breaking Medicine News(10 mins):Health News:A Forever Recovery Holds Autograph Event with Former Detroit Lions at Cherry Festival 2Health News:Heartfelt Interview Shows Extraordinary Impact of CARE Surrogacy Center Mexico 2Health News:Heartfelt Interview Shows Extraordinary Impact of CARE Surrogacy Center Mexico 3Health News:Workplace Trouble: Survey Reveals Sharp Escalation in Restaurant/Food Service Employee Drug Abuse 2Health News:Workplace Trouble: Survey Reveals Sharp Escalation in Restaurant/Food Service Employee Drug Abuse 3
... the prevention of heart disease and is controlled by ... from Leuven, in Belgium, set out to determine whether ... the reduction of blood pressure that accounts for the ... part of a meta-analysis the team compared blood pressure ...
... here is little benefit in replacing older and cheaper ... treating acute, uncomplicated sinusitis, according to US researchers. Researchers ... to determine whether the symptoms could be treated with ... more expensive (second-line) antibiotics. // ,Dr Jay ...
... a way to make wounds heal at least twice ... team at the Australian University of Technology reports they ... number of key hormones involved in the body's own ... ,The researchers believe that although the complex occurs ...
... undergoing high-dose chemotherapy could be eased by electroacupuncture. Nausea ... fight cancer can prove extremely debilitating for patients. ... to lessen the reaction, but in recent years acupuncture ... help. ,Acupuncture involves the insertion of tiny needles at ...
... you ever applied a hot water bottle to an aching ... ache. This treatment delivered with needlepoint accuracy leads to dramatic ... Heat is a long-established method of bringing relief in lower ... the US have developed a high-tech way of using heat.// ...
... first self-contained artificial heart in a 59-year-old man more ... have installed a second such device in a 70-year-old ... recovering in intensive care at Jewish Hospital in Louisville, ... ,The self-contained mechanical heart, made by Abiomed Inc. of ...
Cached Medicine News:
Cleveland Bone Cutter #5, 17cm, 6-3/4"...
To elevate, dissect, scrape and apply traction to bone and soft tissue....
Diamond Point Bone Probe with Ortho-Grip® silicone rubber palm style handles and,stainless steel impactor caps....
The AV Plus DX pacing lead is designed for use with the St. Jude Medical Affinity VDR pulse generator. This single-lead pacing system provides reliable pacing therapy with the added benefits of AV sy...
Medicine Products: